These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 30948625)

  • 21. Metabolic counterparts of sodium accumulation in multiple sclerosis: A whole brain
    Donadieu M; Le Fur Y; Maarouf A; Gherib S; Ridley B; Pini L; Rapacchi S; Confort-Gouny S; Guye M; Schad LR; Maudsley AA; Pelletier J; Audoin B; Zaaraoui W; Ranjeva JP
    Mult Scler; 2019 Jan; 25(1):39-47. PubMed ID: 29064346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI.
    Eisele P; Konstandin S; Griebe M; Szabo K; Wolf ME; Alonso A; Ebert A; Serwane J; Rossmanith C; Hennerici MG; Schad LR; Gass A
    Mult Scler; 2016 Jul; 22(8):1040-7. PubMed ID: 26453681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gray matter microglial activation in relapsing vs progressive MS: A [F-18]PBR06-PET study.
    Singhal T; O'Connor K; Dubey S; Pan H; Chu R; Hurwitz S; Cicero S; Tauhid S; Silbersweig D; Stern E; Kijewski M; DiCarli M; Weiner HL; Bakshi R
    Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e587. PubMed ID: 31355321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gray matter atrophy is related to long-term disability in multiple sclerosis.
    Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
    Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis.
    Ouellette R; Treaba CA; Granberg T; Herranz E; Barletta V; Mehndiratta A; De Leener B; Tauhid S; Yousuf F; Dupont SM; Klawiter EC; Sloane JA; Bakshi R; Cohen-Adad J; Mainero C
    Brain; 2020 Oct; 143(10):2973-2987. PubMed ID: 32935834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.
    Fisniku LK; Altmann DR; Cercignani M; Tozer DJ; Chard DT; Jackson JS; Miszkiel KA; Schmierer K; Thompson AJ; Miller DH
    Mult Scler; 2009 Jun; 15(6):668-77. PubMed ID: 19435751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
    Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased total sodium concentration in gray matter better explains cognition than atrophy in MS.
    Maarouf A; Audoin B; Pariollaud F; Gherib S; Rico A; Soulier E; Confort-Gouny S; Guye M; Schad L; Pelletier J; Ranjeva JP; Zaaraoui W
    Neurology; 2017 Jan; 88(3):289-295. PubMed ID: 27974643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
    Samson RS; Cardoso MJ; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ron M; Ourselin S; Miller DH; Chard DT
    Mult Scler; 2014 Sep; 20(10):1322-30. PubMed ID: 24552746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study.
    Solanky BS; John NA; DeAngelis F; Stutters J; Prados F; Schneider T; Parker RA; Weir CJ; Monteverdi A; Plantone D; Doshi A; MacManus D; Marshall I; Barkhof F; Gandini Wheeler-Kingshott CAM; Chataway J;
    AJNR Am J Neuroradiol; 2020 Dec; 41(12):2209-2218. PubMed ID: 33154071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.
    Anderson VM; Fisniku LK; Altmann DR; Thompson AJ; Miller DH
    Mult Scler; 2009 Jul; 15(7):811-7. PubMed ID: 19465449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.
    Chen X; Schädelin S; Lu PJ; Ocampo-Pineda M; Weigel M; Barakovic M; Ruberte E; Cagol A; Marechal B; Kober T; Kuhle J; Kappos L; Melie-Garcia L; Granziera C
    Neuroimage Clin; 2023; 37():103349. PubMed ID: 36801600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thalamic asymmetry in Multiple Sclerosis.
    Ramezani N; Davanian F; Naghavi S; Riahi R; Zandieh G; Danesh-Mobarhan S; Ashtari F; Shaygannejad V; Sanayei M; Adibi I
    Mult Scler Relat Disord; 2023 Sep; 77():104853. PubMed ID: 37473593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What contributes to disability in progressive MS? A brain and cervical cord-matched quantitative MRI study.
    Tur C; Battiston M; Yiannakas MC; Collorone S; Calvi A; Prados F; Kanber B; Grussu F; Ricciardi A; Pajak P; Martinelli D; Schneider T; Ciccarelli O; Samson RS; Wheeler-Kingshott CAG
    Mult Scler; 2024 Apr; 30(4-5):516-534. PubMed ID: 38372019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Cortical Lesions With Regional Glutamate, GABA,
    Madsen MA; Považan M; Wiggermann V; Lundell H; Blinkenberg M; Romme Christensen J; Sellebjerg F; Siebner HR
    Neurology; 2024 Jul; 103(1):e209543. PubMed ID: 38870443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grey-matter sodium concentration as an individual marker of multiple sclerosis severity.
    Maarouf A; Audoin B; Gherib S; El Mendili MM; Viout P; Pariollaud F; Boutière C; Rico A; Guye M; Ranjeva JP; Zaaraoui W; Pelletier J
    Mult Scler; 2022 Oct; 28(12):1903-1912. PubMed ID: 35723278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topography of brain sodium accumulation in progressive multiple sclerosis.
    Maarouf A; Audoin B; Konstandin S; Rico A; Soulier E; Reuter F; Le Troter A; Confort-Gouny S; Cozzone PJ; Guye M; Schad LR; Pelletier J; Ranjeva JP; Zaaraoui W
    MAGMA; 2014 Feb; 27(1):53-62. PubMed ID: 23907269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.